ResearcherAffiliated Hospital of Qingdao UniversityActive in the last 2 years
Ying Li
Matched on ORCID iD 0000-0002-7651-6543; OpenAlex author ID A5023985119. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers
Papers 4
- Unveiling the immunological terrain of pancreatic ductal adenocarcinoma: strategies to prompt immunotherapy from Mendelian randomization. Co-author DOI 10.1007/s12672-025-02250-7↗
- New Potential Metabolic Biomarker and Its Role in PDAC: Insights from Genome-Wide Association Studies and Single-cell Analysis Co-author DOI 10.21203/rs.3.rs-6697879/v1↗
- The Interplay Between Inflammation and Stromal Components in Pancreatic Cancer. Co-author DOI 10.3389/fimmu.2022.850093↗
- Prediction of Candidate Drugs for Treating Pancreatic Cancer by Using a Combined Approach. Co-author DOI 10.1371/journal.pone.0149896↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jiqiang Li · 2 shared papers, 2025 · strength 0.50
- Paper New Potential Metabolic Biomarker and Its Role in PDAC: Insights from Genome-Wide Association Studies and Single-cell A… DOI 10.21203/rs.3.rs-6697879/v1↗
- Paper Unveiling the immunological terrain of pancreatic ductal adenocarcinoma: strategies to prompt immunotherapy from Mendel… DOI 10.1007/s12672-025-02250-7↗
- Peizan Ni · 2 shared papers, 2025 · strength 0.50
- Paper New Potential Metabolic Biomarker and Its Role in PDAC: Insights from Genome-Wide Association Studies and Single-cell A… DOI 10.21203/rs.3.rs-6697879/v1↗
- Paper Unveiling the immunological terrain of pancreatic ductal adenocarcinoma: strategies to prompt immunotherapy from Mendel… DOI 10.1007/s12672-025-02250-7↗
- Yingxin Wei · 1 shared paper, 2022 · strength 0.19
- Shanglong Liu · 1 shared paper, 2022 · strength 0.19
- Xiaoqin Wang · 1 shared paper, 2016 · strength 0.06
- Yanfen Ma · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.